Chemours Co Stock
€12.47
Your prediction
Chemours Co Stock
Pros and Cons of Chemours Co in the next few years
Pros
Cons
Performance of Chemours Co vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemours Co | -1.350% | 16.237% | 14.551% | -26.605% | 24.116% | -58.777% | -43.303% |
| Quaker Chemical Corp. | 0.000% | 6.667% | 5.785% | 5.785% | 5.785% | - | - |
| RPM International Inc. | 1.050% | 6.111% | 4.372% | -19.068% | 6.111% | 17.901% | 32.639% |
| Albemarle Corp | 3.720% | 16.447% | 28.397% | 71.865% | 17.732% | -35.249% | -2.890% |
Comments
News
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
New York City-based Alta Fundamental Advisers initiated a new position in The Chemours Company (NYSE:CC), acquiring 800,000 shares valued at an estimated $12.67 million, according to a November 13
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company (NYSE:CC) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC
Chemours (CC) Q2 EPS Jumps 53%
Chemours (NYSE:CC), a global chemicals manufacturer known for its fluoroproducts and titanium dioxide pigments, announced its results for Q2 2025 on August 5, 2025. The most notable news was a solid


